Corvus Pharmaceuticals (CRVS)
Nasdaq • CRVS • US2210151005
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 24.6% of free float sold short, 16.2 days to cover, cost to borrow 0.48%. Sign up for live short interest data.
Market Cap
968m USD | # 5053 in US
Volume
1.03m shares | 12.49m USD
Shares Outstanding
84.35m
Free Float Shares
86.57% | 73.02m
